The novel finding that NAC and ALP attenuate high glucose-induced MPTP opening in cardiomyocytes during hypoxia/re-oxygenation via HIF-1α/HO-1 signaling may have potential clinical importance in guiding the development of effective therapies to combat myocardial ischemia in diabetes. Here, HIF1A is linked to diabetes mellitus.